790 



INDEX 



Pneumococcus (cont.): 



transmutation of species, 169-177 



type determination. See Type de- 

 termination 



variants. See Variants 



viability, 49-52 



virulence. See Virulence 



xanthoprotein, formation by, 75 

 Pneumococcus mucosus 



action on inulin, 68 



bile solubility, 56, 57 



reclassification, 110, 361-362 



serological classification, 105, 380 

 Pneumococcus planus, 111 

 Pneumokokkus, 14 

 Pneumonia 



antibodies in blood, 437-442 



associated with other infections, 5, 

 6, 8, 9, 16, 17, 225-229 



broncho-, 219-221 



dermal. See Dermal pneumonia in 

 rabbits 



epidemics. See Epidemics 



etiology. See Etiology 



in infants and children, pneumo- 

 coccal types, 221-222 



lobar. See Lobar pneumonia 



methemoglobin in, 73, 80 



opsonins in, 401-402, 438, 439 



predisposing causes, 15 



serum treatment, 598-612 



skin reactions in, 440, 460-466, 468, 

 473 



tropins in, 401-402, 438, 439 



vaccine therapy, 503-506 

 Pneumoniecoccen, 10 

 Pneumoniekokken, 1, 2 

 Pneumonie-Micrococcen, 1 

 Pneumoniemikrococcus, 1, 15, 19 

 Pneumoniemikrokokken, 8 

 Pneumotoxin as antigen, 338 

 Poisons, protein, relation to pneumo- 

 coccal toxins, 100-101 

 Polymorphonuclear leucocytes in nat- 

 ural immunity, 432 

 Polyphasic cycle in dissociation, 154 

 Polysaccharide ( s ) 



acetyl. See Acetyl carbohydrate- 



azoproteins ; Acetyl polysaccha- 

 ride^) 



antigenicity, 251, -255, 283, 290, 292, 

 344-345, 349, 448 



B. friedlanderi, 246, 260, 262 



B. tuberculosis , 262 



C Fraction. See C Fraction 



capsular. See A substance; Cap- 

 sular polysaccharide (s) ; Carbo- 

 hydrates, cellular 



dextran, 70, 261 



elimination, 350, 487 



Escherichia coli, 262 



fractions, acid-soluble and acid- 

 insoluble, 276 



gum arabic, 261 



levan, 70 



optical rotation. See Optical rota- 

 tion 



phosphorus in, 271, 287 



production of, in broth, 623-625, 634 



purpurigenic action of. See Pur- 

 pura 



relation of pneumococcal to non- 

 pneumococcal, 258-263 



sulfur in, 271, 287 

 Polysaccharide-splitting enzymes. See 

 Enzymes, polysaccharide-splitting 

 Polytrope medium as differential me- 

 dium, 48 

 Polyvalent serum, 545-547 

 Pooled serums in type determination, 



129 

 Post-mortem cultures, 230 

 Potency tests on antipneumococcic se- 

 rum, 28, 565-587 



agglutination, 582 



American Drug Manufacturers' As- 

 sociation, 570, 651-653 



animal tests, early, 565-566 



antitoxic flocculation, 581 



antitoxin, 579 



bactericidal power, 581 



combining equivalents, 584 



complement fixation, 581 



correlation between in vitro and in 

 vivo tests, 584-587 



exudate antiserum, 579 



